Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Abstract Encephalomyocarditis virus (EMCV), a potential zoonotic pathogen, poses significant socioeconomic and public health challenges across various host species. Although EMCV rarely triggers severe clinical symptoms in humans, its widespread prevalence and unique biological characteristics under...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanfang Zhang, Zhiying Wang, Yaohui Fang, Qiong Zhu, Jie Fu, Sijing Hu, Jiayin Jin, Min Zhou, Xijia Liu, Danna Zhang, Shouwei Huang, Yali Deng, Lingling Xie, Shu Shen, Jing Ye, Fei Deng, Shengbo Cao
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Animal Diseases
Subjects:	Encephalomyocarditis virus Monoclonal antibody Virus-like particles Neutralizing activity Therapeutic efficacy Antiviral development
Online Access:	https://doi.org/10.1186/s44149-024-00154-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimizing encephalomyocarditis virus VP1 protein assembly on pseudorabies virus envelope via US9 protein anchoring
by: Bao Ru Ren, et al.
Published: (2025-12-01)

Insertion of a G-quadruplex or hairpin structure into the 5' UTR or poly(A) sequences reduces translation efficiency of the encephalomyocarditis virus internal ribosome entry site: a preclinical in vitro study
by: Yun Ji Kim, et al.
Published: (2025-07-01)

THE ENCEPHALOMYOCARDITIS VIRUS (EMCV) AND ITS ZOONOTIC POTENTIAL (A Literature Review) PART I. MODERN VIEWS ON THE EMCV STRUCTURE AND ITS VIRAL CYCLE
by: Akop A. Kalajdzhjan, et al.
Published: (2019-05-01)

A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses
by: Dong Chen, et al.
Published: (2024-12-01)

A potential surrogate for poliovirus in testing the efficacy of hand antiseptics according to the Global Poliovirus Containment Action Plan
by: Eggers, Maren, et al.
Published: (2025-07-01)

Monoclonal Antibodies for COVID-19 Treatment: Is It an Option in Indonesia?
by: Alvina Widhani
Published: (2023-11-01)

Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
by: Isabella Hrabal, et al.
Published: (2025-03-01)

Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review
by: Sharana Mahomed, et al.
Published: (2025-04-01)

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus
by: Fan Yang, et al.
Published: (2020-01-01)

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
by: Nuttapat Pisuttinusart, et al.
Published: (2024-12-01)

Generation and application of two monoclonal antibodies targeting conserved linear epitopes in the NP protein of influenza A virus
by: Yu-hui ZHAO, et al.
Published: (2022-07-01)

Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
by: Mallory L. Myers, et al.
Published: (2025-05-01)

Production and application of monoclonal antibodies against Potato virus X
by: WU Jian-xiang, et al.
Published: (2005-09-01)

A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections
by: Amanda E. Calvert, et al.
Published: (2025-06-01)

Monoclonal antibodies for characterization of rabies virus isolated from non-hematophagous bats in Brazil
by: Luciana Botelho Chaves, et al.
Published: (2015-11-01)

Identification and Characterization of Linear Epitopes of Monoclonal Antibodies Against African Horse Sickness Virus Serotype 1 VP2 Protein
by: Xiaohua Ma, et al.
Published: (2024-11-01)

A combination of two human monoclonal antibodies cures symptomatic rabies
by: Guilherme Dias de Melo, et al.
Published: (2020-09-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Research trends in anti-rabies virus monoclonal antibody: A bibliometric analysis
by: Cheng Liu, et al.
Published: (2025-12-01)

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
by: Courtney Woolsey, et al.
Published: (2024-12-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model
by: Xuefeng Niu, et al.
Published: (2019-01-01)

Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models
by: Nereida Jiménez de Oya, et al.
Published: (2019-01-01)

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024-12-01)

Monoclonal antibody and B-cell epitope mapping of the VP7 protein in bluetongue virus
by: Xin-Bing Hu, et al.
Published: (2025-04-01)

Identification of a New Conserved Antigenic Epitope by Specific Monoclonal Antibodies Targeting the African Swine Fever Virus Capsid Protein p17
by: Nengwen Xia, et al.
Published: (2024-12-01)

Impact of routine prophylaxis with monoclonal antibodies and maternal immunisation to prevent respiratory syncytial virus hospitalisations, Lombardy region, Italy, 2024/25 season
by: Piero Poletti
Published: (2025-04-01)

Preparation and identification of a novel monoclonal antibody against African swine fever virus p15 protein
by: Jian He, et al.
Published: (2025-08-01)

Prokaryotic expression of βC1 gene of DNAβ satellite associated with Tobacco curly shoot virus and preparation of monoclonal antibodies against its protein
by: JIANG Lei, et al.
Published: (2008-03-01)

Identification of Conserved Linear Epitopes on Viral Protein 2 of Foot-and-Mouth Disease Virus Serotype O by Monoclonal Antibodies 6F4.D11.B6 and 8D6.B9.C3
by: Wantanee Tommeurd, et al.
Published: (2024-08-01)

Direct antiviral drugs and blocking monoclonal antibodies as the basis of etiotropic therapy of a novel coronavirus infection
by: V. B. Musatov
Published: (2022-10-01)

Inhibitory effect of curcumin on duck tembusu virus
by: Dongdong Yin, et al.
Published: (2025-08-01)

Virucidal activity of tiliacorinine, dioscorine, racemosol, and terrein against influenza A virus (H1N1), coronavirus 229E, SARS-CoV-2, and enterovirus 71
by: Akanitt Jittmittraphap, et al.
Published: (2025-04-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

The Novel Antigenic Epitopes of African Swine Fever Virus Inner Membrane p54 Protein Revealed by Monoclonal Antibodies
by: Jiajia Zhang, et al.
Published: (2025-04-01)

Designing Sandwich ELISA with Broadly Reactive Anti-Nucleocapsid Monoclonal Antibodies to Detect Bat-Borne Merbecoviruses
by: Kong Yen Liew, et al.
Published: (2025-06-01)

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
by: Fei-Fei Xiong, et al.
Published: (2020-01-01)

Isolation and Characterization of E8 Monoclonal Antibodies from Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient Neutralization of Authentic Monkeypox Virus
by: Yutao Shi, et al.
Published: (2025-04-01)

Global Pediatric Pulmonology Alliance recommendations to protect all infants against respiratory syncytial virus with prophylactic monoclonal antibodies
by: Kunling Shen, et al.
Published: (2025-03-01)

Inhibiting the Replication of the Dengue Virus Using In Vitro Influcid
by: O. V. Pyankov, et al.
Published: (2020-05-01)